Scrip’s Five Must-Know Things – 4 September 2023

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: US Medicare price negotiations get soft landing; Medicare negotiations and patent cliff acceleration; Novo Nordisk steps into heart failure; PCSK9s and the convenience battle; and an investor’s view of Korean biotech potential. https://scrip.pharmaintelligence.informa.com/SC148990/Quick-Listen-Scrips-Five-MustKnow-Things